As of 2025-05-17, the Intrinsic Value of Monash IVF Group Ltd (MVF.AX) is 0.00 AUD. This MVF.AX valuation is based on the model Discounted Cash Flows (EBITDA Exit 5Y). With the current market price of 0.88 AUD, the upside of Monash IVF Group Ltd is -99.90%.
The range of the Intrinsic Value is (0.02) - 0.03 AUD
Based on its market price of 0.88 AUD and our intrinsic valuation, Monash IVF Group Ltd (MVF.AX) is overvalued by 99.90%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | (1.00) - (0.48) | (0.53) | -161.0% |
| DCF (Growth 10y) | (0.45) - (0.70) | (0.48) | -155.0% |
| DCF (EBITDA 5y) | (0.02) - 0.03 | 0.00 | -99.9% |
| DCF (EBITDA 10y) | (0.00) - 0.09 | 0.04 | -95.9% |
| Fair Value | -0.03 - -0.03 | -0.03 | -103.36% |
| P/E | (0.09) - (0.10) | (0.10) | -111.7% |
| EV/EBITDA | (0.06) - 0.17 | 0.07 | -92.4% |
| EPV | 0.93 - 1.37 | 1.15 | 31.4% |
| DDM - Stable | (0.07) - (0.40) | (0.23) | -126.9% |
| DDM - Multi | (0.16) - (0.73) | (0.27) | -130.6% |
| Market Cap (mil) | 340.93 |
| Beta | 0.69 |
| Outstanding shares (mil) | 389.63 |
| Enterprise Value (mil) | 492.81 |
| Market risk premium | 5.10% |
| Cost of Equity | 7.60% |
| Cost of Debt | 5.00% |
| WACC | 6.41% |